New injection could stop pancreatitis from turning deadly

NCT ID NCT06080789

First seen Jun 24, 2026 · Last updated Aug 06, 2026 · Updated 3 times

Summary

This study tests a single injection of a drug called RABI-767, given through a scope into the area around the pancreas, for people with predicted severe acute pancreatitis. About 36 participants will be randomly assigned to get the drug plus standard care or standard care alone. The goal is to see if the drug is safe and can prevent the condition from getting worse.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
RABI-767
What this could lead to
If it works, this could point toward a treatment that prevents severe acute pancreatitis from becoming life-threatening.
What could go wrong
This is a small, early-phase trial with only 36 participants, so results may not apply to everyone. The drug is injected directly into the pancreas area, which carries risks like bleeding or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE PANCREATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • All India Institute of Medical Sciences

    RECRUITING

    Delhi, 110029, India

  • Christian Medical College (CMC) Vellore, Ranipet Campus

    RECRUITING

    Vellore, TamiNadu, 632517, India

  • Dartmouth Hitchcock Medical Center

    RECRUITING

    Lebanon, New Hampshire, 03756, United States

  • Govind Ballabh Pant Institute of Postgraduate Medical Education and Research

    RECRUITING

    New Delhi, 110002, India

  • Henry Ford Hospital

    RECRUITING

    Detroit, Michigan, 48202, United States

  • Indiana University Health University Hospital

    WITHDRAWN

    Indianapolis, Indiana, 46202, United States

  • Johns Hopkins Hospital

    RECRUITING

    Baltimore, Maryland, 21287, United States

  • Keck Hospital of USC and LA County Hospital

    RECRUITING

    Los Angeles, California, 90033, United States

  • Lisie Hospital

    RECRUITING

    Kochi, Kerala, 682018, India

  • NYU Langone Medical Center

    RECRUITING

    New York, New York, 10016, United States

  • Orlando Health

    RECRUITING

    Orlando, Florida, 32806, United States

  • Postgraduate Institute of Medical Education and Research

    RECRUITING

    Chandigarh, India

  • UI Health, University of Illinois Chicago Hospital Health Sciences System

    RECRUITING

    Chicago, Illinois, 60612, United States

  • University of Arkansas for Medical Sciences

    RECRUITING

    Little Rock, Arkansas, 72205, United States

  • University of Colorado Anschutz Medical Campus

    RECRUITING

    Aurora, Colorado, 80045, United States

  • University of Florida Health

    RECRUITING

    Gainesville, Florida, 32608, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.